MannKind Corp. (MNKD)
2.835
-0.12
(-3.90%)
USD |
NASDAQ |
Mar 05, 16:00
2.86
+0.02
(+0.88%)
After-Hours: 20:00
MannKind Cash from Investing (TTM) : -304.80M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Amicus Therapeutics, Inc. | -46.43M |
| United Therapeutics Corp. | -551.30M |
| Keros Therapeutics, Inc. | -1.706M |
| BioMarin Pharmaceutical, Inc. | -414.24M |
| Ionis Pharmaceuticals, Inc. | -277.78M |